AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Hemophilia Treatment Drugs Market Drivers, Restraints & Opportunities During the Forecast Period, 2018-2026 - ResearchAndMarkets.com

December 24, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Dec 24, 2019--

The “Hemophilia Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026” report has been added to ResearchAndMarkets.com’s offering.

Hemophilia Treatment Drugs Market - Overview

Hemophilia treatment drugs are products that are administered into the patient’s body in order to replace the blood clotting factors that are missing in their blood so that the blood can clot properly. This report analyzes the current and future prospects of the hemophilia treatment drugs market based on product type, disease indication, distribution channel, and region.

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of hemophilia treatment drugs market in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market value in terms of US$ Mn for product type, disease indication, distribution channel, and region for the period 2018 to 2026.

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors would help the market players to decide about the business strategies and plans to strengthen their positions in the global market.

Strategic collaboration agreements and new product development was the primary strategy adopted by major market players to bolster their position in the hemophilia treatment drugs market.

Key Topics Covered:

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Hemophilia Treatment Drugs Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.4. Global Hemophilia Treatment Drugs Market Analysis and Forecast, 2016-2026

4.5. Porter’s Five Force Analysis

5. Market Outlook

5.1. Regulatory Scenario by Region/globally

5.2. Key Mergers & Acquisitions

5.3. Pipeline Analysis

5.4. Clinical Trial Analysis

5.5. Technological Advancements

6. Global Hemophilia Treatment Drugs Market Analysis and Forecast, by Product Type

6.1. Introduction & Definition

6.2. Key Findings/Developments

6.3. Global Hemophilia Treatment Drugs Market Value Forecast, by Product Type, 2016-2026

6.4. Global Hemophilia Treatment Drugs Market Attractiveness, by Product Type

7. Global Hemophilia Treatment Drugs Market Analysis and Forecast, by Disease Indication

7.1. Introduction & Definition

7.2. Key Findings/Developments

7.3. Global Hemophilia Treatment Drugs Market Value Forecast by Disease Indication, 2016-2026

7.4. Global Hemophilia Treatment Drugs Market Attractiveness, by Disease Indication

8. Global Hemophilia Treatment Drugs Market Analysis and Forecast, by Distribution Channel

8.1. Introduction & Definition

8.2. Key Findings/Developments

8.3. Global Hemophilia Treatment Drugs Market Value Forecast, by Distribution Channel, 2016-2026

8.4. Global Hemophilia Treatment Drugs Market Attractiveness, by Distribution Channel

9. Global Hemophilia Treatment Drugs Market Analysis and Forecast, by Region

9.1. Key Findings

9.2. Global Hemophilia Treatment Drugs Market Value Forecast, by Region

9.3. Global Hemophilia Treatment Drugs Market Attractiveness, by Country/Region

10. North America Hemophilia Treatment Drugs Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. North America Hemophilia Treatment Drugs Market Value Forecast, by Product Type, 2016-2026

10.3. North America Hemophilia Treatment Drugs Market Value Forecast, by Disease Indication, 2016-2026

10.4. North America Hemophilia Treatment Drugs Market Value Forecast, by Distribution Channel, 2016-2026

10.5. North America Hemophilia Treatment Drugs Market Value Forecast by Country, 2016-2026

10.6. North America Hemophilia Treatment Drugs Market Attractiveness Analysis

11. Europe Hemophilia Treatment Drugs Market Analysis and Forecast

12. Asia Pacific Hemophilia Treatment Drugs Market Analysis and Forecast

13. Latin America Hemophilia Treatment Drugs Market Analysis and Forecast

14. Middle East & Africa Hemophilia Treatment Drugs Market Analysis and Forecast

15. Competition Landscape

15.1.Market Player - Competition Matrix (by Tier and Size of companies)

15.2.Market Share Analysis by Company (2017)

15.3. Company Profiles

15.3.1. Biotest AG.

15.3.2. Bayer AG

15.3.3. CSL Limited

15.3.4. F. Hoffmann-La Roche Ltd.

15.3.5. Kedrion

15.3.6. Novo Nordisk A/S

15.3.7. Octapharma

15.3.8. Pfizer, Inc

15.3.9. Sanofi

15.3.10. Shire Plc.

For more information about this report visit https://www.researchandmarkets.com/r/adi2zn

View source version on businesswire.com:https://www.businesswire.com/news/home/20191224005091/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 12/24/2019 06:44 AM/DISC: 12/24/2019 06:44 AM

http://www.businesswire.com/news/home/20191224005091/en